Evidence map›Paper›PMID 30171847›Full record

ArticleJournal of molecular and cellular cardiology2018

Insights from molecular signature of in vivo cardiac c-Kit(+) cells following cardiac injury and β-catenin inhibition.

Conrad P Hodgkinson, José A Gomez, Syeda Samara Baksh, Alan Payne, Jeffrey Schmeckpeper, Richard E Pratt, Victor J Dzau

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The role of β-catenin in cardiac diseases.Frontiers in pharmacology · 2023
    Review
  12. Conservation of miR combo based direct cardiac reprogramming.Biochemistry and biophysics reports · 2022
    Article
  13. Article
  14. A role for Sfrp2 in cardiomyogenesis in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  15. Article
  16. Review
  17. Review
  18. Role of c-Kit in Myocardial Regeneration and Aging.Frontiers in endocrinology · 2019
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Conrad P HodgkinsonMandel Center for Heart and Vascular Research, The Cardiovascular Research Center, Duke University Medical Center, Durham, NC 27710, United States. Electronic address: conrad.hodgkinson@duke.edu.
José A GomezMandel Center for Heart and Vascular Research, The Cardiovascular Research Center, Duke University Medical Center, Durham, NC 27710, United States; Deparment of Medicine, Clinical Pharmacology Division, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
Syeda Samara BakshMandel Center for Heart and Vascular Research, The Cardiovascular Research Center, Duke University Medical Center, Durham, NC 27710, United States.
Alan PayneMandel Center for Heart and Vascular Research, The Cardiovascular Research Center, Duke University Medical Center, Durham, NC 27710, United States.
Jeffrey SchmeckpeperMandel Center for Heart and Vascular Research, The Cardiovascular Research Center, Duke University Medical Center, Durham, NC 27710, United States.
Richard E PrattMandel Center for Heart and Vascular Research, The Cardiovascular Research Center, Duke University Medical Center, Durham, NC 27710, United States.
Victor J DzauMandel Center for Heart and Vascular Research, The Cardiovascular Research Center, Duke University Medical Center, Durham, NC 27710, United States. Electronic address: victor.dzau@duke.edu.
Duke Medical Center · USDuke University Hospital · USVanderbilt University Medical Center · US

Funding

GENE THERAPY FOR LONG-TERM MYOCARDIAL PROTECTIONR01HL072010 · NHLBI · DUKE UNIVERSITY · PI DZAU, VICTOR J · 2003 to 2013
$4.5M
Sfrp2 as a Stem Cell Derived Paracrine Factor for CardioprotectionR01HL081744 · NHLBI · DUKE UNIVERSITY · PI DZAU, VICTOR J · 2006 to 2015
$3.8M
RENIN GENE EXPRESSION IN HYPERTENSIONR01HL035610 · NHLBI · STANFORD UNIVERSITY · PI DZAU, VICTOR J · 1985 to 2011
$3.6M
Homing and Genetic Modification of Mesenchymal Stem CellR01HL073219 · NHLBI · DUKE UNIVERSITY · PI DZAU, VICTOR J · 2003 to 2012
$3.5M
Sfrp2 induces in situ c-Kit cell differentiation into cardiomyocytes via Wnt11-Fzd5 mediated b-catenin inhibitionR01HL139718 · NHLBI · DUKE UNIVERSITY · PI DZAU, VICTOR J · 2018 to 2021
$1.6M
Sox6 Role in Renin Expression During Juxtaglomerular Cells ExpansionK01HL135461 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GOMEZ, JOSE A. · 2017 to 2021
$850k
NHLBI NIH HHS K01 HL135461NHLBI NIH HHS R01 HL035610NHLBI NIH HHS R01 HL072010NHLBI NIH HHS R01 HL073219NHLBI NIH HHS R01 HL081744NHLBI NIH HHS R01 HL139718
6 · The paper itself

Abstract

There is much interest over resident c-Kit(+) cells in tissue regeneration. Their role in cardiac regeneration has been controversial. In this study we aim to understand the in vivo behavior of cardiac c-Kit(+) cells at baseline and after myocardial infarction and in response to Sfrp2. This approach can accurately study the in vivo transcript expressions of these cells in temporal response to injury and overcomes the limitations of the in vitro approach. RNA-seq was performed with c-Kit(+) cells and cardiomyocytes from healthy non-injured mice as well as c-Kit(+) cells from 1 day post-MI and 12 days post-MI mice. When compared to in vivo c-Kit(+) cells isolated from a healthy non-injured mouse heart, cardiomyocytes were enriched in transcripts that express anion channels, cation channels, developmental/differentiation pathway components, as well as proteins that inhibit canonical Wnt/β-catenin signaling. Myocardial infarction (MI) induced in vivo c-Kit(+) cells to transiently adopt the cardiomyocyte-specific signature: expression of a number of cardiomyocyte-specific transcripts was maximal 1 day post-MI and declined by 12 days post-MI. We next studied the effect of β-catenin inhibition on in vivo c-Kit(+) cells by administering the Wnt inhibitor Sfrp2 into the infarct border zone. Sfrp2 both enhanced and sustained cardiomyocyte-specific gene expression in the in vivo c-Kit(+) cells: expression of cardiomyocyte-specific transcripts was higher and there was no decline in expression by 12 days post-MI. Further analysis of the biology of c-Kit(+) cells identified that culture induced a significant and irreversible change in their molecular signature raising questions about reliability of in vitro studies. Our findings provide evidence that MI induces in vivo c-Kit(+) cells to adopt transiently a cardiomyocyte-specific pattern of gene expression, and Sfrp2 further enhances and induces sustained gene expression. Our approach is important for understanding c-Kit(+) cells in cardiac regeneration and also has broad implications in the investigation of in vivo resident stem cells in other areas of tissue regeneration.

Indexed as

Animalsbeta CateninCell DifferentiationComputational BiologyDisease Models, AnimalGene Expression ProfilingGene Expression RegulationHeart InjuriesIon ChannelsMiceMice, KnockoutMyoblastsMyocardial InfarctionMyocytes, CardiacOrgan SpecificityProto-Oncogene Proteins c-kitbeta CateninIon ChannelsProto-Oncogene Proteins c-kitCell differentiationHeart injuries/pathologyHeart stem cellsProto-oncogene proteins c-kit/metabolismWnt signaling pathway

Identifiers

PMID30171847
PMCPMC6192834
OpenAlexW2889270927

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.